These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26385727)

  • 1. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
    Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
    BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of oral anticoagulants and risk of prostate cancer: a population-based case-control study in Montreal, Canada.
    Blanc-Lapierre A; Weiss D; Parent MÉ
    Cancer Causes Control; 2014 Sep; 25(9):1159-66. PubMed ID: 24946744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissecting the association between metabolic syndrome and prostate cancer risk: analysis of a large clinical cohort.
    Bhindi B; Locke J; Alibhai SMH; Kulkarni GS; Margel DS; Hamilton RJ; Finelli A; Trachtenberg J; Zlotta AR; Toi A; Hersey KM; Evans A; van der Kwast TH; Fleshner NE
    Eur Urol; 2015 Jan; 67(1):64-70. PubMed ID: 24568896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General and abdominal obesity trajectories across adulthood, and risk of prostate cancer: results from the PROtEuS study, Montreal, Canada.
    Vallières E; Mésidor M; Roy-Gagnon MH; Richard H; Parent MÉ
    Cancer Causes Control; 2021 Jun; 32(6):653-665. PubMed ID: 33818663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study.
    Sourbeer KN; Howard LE; Andriole GL; Moreira DM; Castro-Santamaria R; Freedland SJ; Vidal AC
    BJU Int; 2015 May; 115(5):736-43. PubMed ID: 24931061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occupation, industry, and the risk of prostate cancer: a case-control study in Montréal, Canada.
    Sauvé JF; Lavoué J; Parent MÉ
    Environ Health; 2016 Oct; 15(1):100. PubMed ID: 27769264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actual lowering effect of metabolic syndrome on serum prostate-specific antigen levels is partly concealed by enlarged prostate: results from a large-scale population-based study.
    Zhao S; Xia M; Tang J; Yan Y
    BJU Int; 2017 Oct; 120(4):482-489. PubMed ID: 27489082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
    Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome and risk of Parkinson disease: A nationwide cohort study.
    Nam GE; Kim SM; Han K; Kim NH; Chung HS; Kim JW; Han B; Cho SJ; Yu JH; Park YG; Choi KM
    PLoS Med; 2018 Aug; 15(8):e1002640. PubMed ID: 30130376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residential greenness and risk of prostate cancer: A case-control study in Montreal, Canada.
    Demoury C; Thierry B; Richard H; Sigler B; Kestens Y; Parent ME
    Environ Int; 2017 Jan; 98():129-136. PubMed ID: 27823799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Traffic-related air pollution and prostate cancer risk: a case-control study in Montreal, Canada.
    Parent MÉ; Goldberg MS; Crouse DL; Ross NA; Chen H; Valois MF; Liautaud A
    Occup Environ Med; 2013 Jul; 70(7):511-8. PubMed ID: 23531743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circumcision and prostate cancer: a population-based case-control study in Montréal, Canada.
    Spence AR; Rousseau MC; Karakiewicz PI; Parent MÉ
    BJU Int; 2014 Dec; 114(6b):E90-E98. PubMed ID: 24655933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BPH: a tell-tale sign of prostate cancer? Results from the Prostate Cancer and Environment Study (PROtEuS).
    Boehm K; Valdivieso R; Meskawi M; Larcher A; Sun M; Sosa J; Blanc-Lapierre A; Weiss D; Graefen M; Saad F; Parent MÉ; Karakiewicz PI
    World J Urol; 2015 Dec; 33(12):2063-9. PubMed ID: 25824539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trace proteinuria by dipstick screening is associated with metabolic syndrome, hypertension, and diabetes.
    Okada R; Yasuda Y; Tsushita K; Wakai K; Hamajima N; Matsuo S
    Clin Exp Nephrol; 2018 Dec; 22(6):1387-1394. PubMed ID: 29934666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and low high-density lipoprotein cholesterol are associated with adverse pathological features in patients with prostate cancer treated by radical prostatectomy.
    Lebdai S; Mathieu R; Leger J; Haillot O; Vincendeau S; Rioux-Leclercq N; Fournier G; Perrouin-Verbe MA; Doucet L; Azzouzi AR; Rigaud J; Renaudin K; Charles T; Bruyere F; Fromont G
    Urol Oncol; 2018 Feb; 36(2):80.e17-80.e24. PubMed ID: 29153942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Components of metabolic syndrome and prognosis of renal cell cancer.
    Eskelinen TJ; Kotsar A; Tammela TLJ; Murtola TJ
    Scand J Urol; 2017 Dec; 51(6):435-441. PubMed ID: 28743221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study.
    Montella M; Di Maso M; Crispo A; Grimaldi M; Bosetti C; Turati F; Giudice A; Libra M; Serraino D; La Vecchia C; Tambaro R; Cavalcanti E; Ciliberto G; Polesel J
    BMC Cancer; 2015 Oct; 15():720. PubMed ID: 26475132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The metabolic syndrome and risk of prostate cancer in Italy.
    Pelucchi C; Serraino D; Negri E; Montella M; Dellanoce C; Talamini R; La Vecchia C
    Ann Epidemiol; 2011 Nov; 21(11):835-41. PubMed ID: 21982487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment Study.
    Boehm K; Sun M; Larcher A; Blanc-Lapierre A; Schiffmann J; Graefen M; Sosa J; Saad F; Parent MÉ; Karakiewicz PI
    Urol Oncol; 2015 Nov; 33(11):494.e1-7. PubMed ID: 26278366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial variations in ambient ultrafine particle concentrations and the risk of incident prostate cancer: A case-control study.
    Weichenthal S; Lavigne E; Valois MF; Hatzopoulou M; Van Ryswyk K; Shekarrizfard M; Villeneuve PJ; Goldberg MS; Parent ME
    Environ Res; 2017 Jul; 156():374-380. PubMed ID: 28395241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.